182 related articles for article (PubMed ID: 34189145)
1. The Synergistic Antitumor Effect of Tanshinone IIA Plus Adriamycin on Human Hepatocellular Carcinoma Xenograft in BALB/C Nude Mice and Their Influences on Cytochrome P450 CYP3A4
Liu TL; Zhang LN; Gu YY; Lin MG; Xie J; Chen YL; Liu JH; Wu XL; Mo SL
Adv Med; 2020; 2020():6231751. PubMed ID: 34189145
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA ameliorates dextran sulfate sodium-induced inflammatory bowel disease via the pregnane X receptor.
Zhang X; Wang Y; Ma Z; Liang Q; Tang X; Hu D; Tan H; Xiao C; Gao Y
Drug Des Devel Ther; 2015; 9():6343-62. PubMed ID: 26674743
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA exerts protective effects in a LCA-induced cholestatic liver model associated with participation of pregnane X receptor.
Zhang X; Ma Z; Liang Q; Tang X; Hu D; Liu C; Tan H; Xiao C; Zhang B; Wang Y; Gao Y
J Ethnopharmacol; 2015 Apr; 164():357-67. PubMed ID: 25660334
[TBL] [Abstract][Full Text] [Related]
4. The antitumor effect of tanshinone IIA on anti-proliferation and decreasing VEGF/VEGFR2 expression on the human non-small cell lung cancer A549 cell line.
Xie J; Liu J; Liu H; Liang S; Lin M; Gu Y; Liu T; Wang D; Ge H; Mo SL
Acta Pharm Sin B; 2015 Nov; 5(6):554-63. PubMed ID: 26713270
[TBL] [Abstract][Full Text] [Related]
5. Effects of salvianolic acid B and tanshinone IIA on the pharmacokinetics of losartan in rats by regulating the activities and expression of CYP3A4 and CYP2C9.
Wang R; Zhang H; Wang Y; Yu X; Yuan Y
J Ethnopharmacol; 2016 Mar; 180():87-96. PubMed ID: 26806573
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells.
Jeon YJ; Kim JS; Hwang GH; Wu Z; Han HJ; Park SH; Chang W; Kim LK; Lee YM; Liu KH; Lee MY
Eur J Pharmacol; 2015 Oct; 764():480-488. PubMed ID: 26209360
[TBL] [Abstract][Full Text] [Related]
8. Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study.
Liu YH; Mo SL; Bi HC; Hu BF; Li CG; Wang YT; Huang L; Huang M; Duan W; Liu JP; Wei MQ; Zhou SF
Xenobiotica; 2011 Apr; 41(4):259-80. PubMed ID: 21117944
[TBL] [Abstract][Full Text] [Related]
9. PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA.
Yu C; Ye S; Sun H; Liu Y; Gao L; Shen C; Chen S; Zeng S
Chem Biol Interact; 2009 Jan; 177(1):58-64. PubMed ID: 18805405
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo.
Chien SY; Kuo SJ; Chen YL; Chen DR; Cheng CY; Su CC
Mol Med Rep; 2012 Jan; 5(1):282-6. PubMed ID: 22002472
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA Protects Endothelial Cells from H₂O₂-Induced Injuries via PXR Activation.
Zhu H; Chen Z; Ma Z; Tan H; Xiao C; Tang X; Zhang B; Wang Y; Gao Y
Biomol Ther (Seoul); 2017 Nov; 25(6):599-608. PubMed ID: 28173640
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Ang2/Tie2 Axis with Tanshinone IIA Elicits Vascular Normalization in Ischemic Injury and Colon Cancer.
Zou W; Qian C; Zhang S; Wan X; Wei Z; Li X; Wu Y; Chen W; Wang A; Zhao Y; Lu Y
Oxid Med Cell Longev; 2021; 2021():7037786. PubMed ID: 34804370
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.
Chiu SC; Huang SY; Chen SP; Su CC; Chiu TL; Pang CY
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):315-22. PubMed ID: 24042854
[TBL] [Abstract][Full Text] [Related]
15. Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling.
Liu C; Li J; Wang L; Wu F; Huang L; Xu Y; Ye J; Xiao B; Meng F; Chen S; Yang M
BMC Complement Altern Med; 2012 Jan; 12():5. PubMed ID: 22248096
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA triggers p53 responses and apoptosis by RNA polymerase II upon DNA minor groove binding.
Zhang Z; Gao J; Wang Y; Song T; Zhang J; Wu G; Zhang T; Du G
Biochem Pharmacol; 2009 Nov; 78(10):1316-22. PubMed ID: 19591811
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Huang SY; Chang SF; Liao KF; Chiu SC
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA promotes vascular normalization and boosts Sorafenib's anti-hepatoma activity via modulating the PI3K-AKT pathway.
Qin C; Liu S; Zhou S; Xia X; Hu J; Yu Y; Ma D
Front Pharmacol; 2023; 14():1189532. PubMed ID: 37324455
[No Abstract] [Full Text] [Related]
19. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl‑1 and Bcl‑xL and increasing Bax and CHOP protein expression.
Su CC
Int J Mol Med; 2014 Dec; 34(6):1661-8. PubMed ID: 25270224
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous induction of apoptosis and necroptosis by Tanshinone IIA in human hepatocellular carcinoma HepG2 cells.
Lin CY; Chang TW; Hsieh WH; Hung MC; Lin IH; Lai SC; Tzeng YJ
Cell Death Discov; 2016; 2():16065. PubMed ID: 27752362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
